Search research articles
Contact Us
Filters
Showing results (411-420 of 501) with videos related to
Page
of 51
Sort By:
Materials Today. Bio
|
March 12, 2020
Microfluidic nutrient gradient-based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model
J Rosser, B Bachmann, C Jordan, et al.
Experimental and Molecular Pathology
|
March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer
Toru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
Biochemistry
|
January 28, 2009
Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties
Caroli Genis, Katherine H Sippel, Nicolette Case, et al.
Oncotargets and Therapy
|
September 23, 2021
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
Alexis LeVee, Ching Ying Lin, Edwin Posadas, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 19, 2024
Nasal Epithelium Transcriptomics Predict Clinical Response to Elexacaftor/Tezacaftor/Ivacaftor
Molin Yue, Daniel J Weiner, Kristina M Gaietto, et al.
Journal of the National Medical Association
|
July 16, 2004
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
Charles J Rosser, Deborah A Kuban, Sang-Joon Lee, et al.
Neoplasia (New York, N.Y.)
|
March 4, 2017
Corrigendum to "CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer" [Neoplasia 18 (2016) 636-646]
Makito Miyake, Shunta Hori, Yosuke Morizawa, et al.
Nano Letters
|
November 2, 2023
Imaging Proteins Sensitive to Direct Fusions Using Transient Peptide-Peptide Interactions
Zoe Gidden, Curran Oi, Emily J Johnston, et al.
Plos One
|
June 5, 2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion
Evan Gomes-Giacoia, Makito Miyake, Steve Goodison, et al.
Cancer Gene Therapy
|
July 24, 2002
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer
Motoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, et al.
Page
of 51
Search research articles
Search
Showing results (411-420 of 501) with videos related to
Sort By:
Page
of 51
Materials Today. Bio
|
March 12, 2020
Microfluidic nutrient gradient-based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model
J Rosser, B Bachmann, C Jordan, et al.
Experimental and Molecular Pathology
|
March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer
Toru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
Biochemistry
|
January 28, 2009
Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties
Caroli Genis, Katherine H Sippel, Nicolette Case, et al.
Oncotargets and Therapy
|
September 23, 2021
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
Alexis LeVee, Ching Ying Lin, Edwin Posadas, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 19, 2024
Nasal Epithelium Transcriptomics Predict Clinical Response to Elexacaftor/Tezacaftor/Ivacaftor
Molin Yue, Daniel J Weiner, Kristina M Gaietto, et al.
Journal of the National Medical Association
|
July 16, 2004
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
Charles J Rosser, Deborah A Kuban, Sang-Joon Lee, et al.
Neoplasia (New York, N.Y.)
|
March 4, 2017
Corrigendum to "CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer" [Neoplasia 18 (2016) 636-646]
Makito Miyake, Shunta Hori, Yosuke Morizawa, et al.
Nano Letters
|
November 2, 2023
Imaging Proteins Sensitive to Direct Fusions Using Transient Peptide-Peptide Interactions
Zoe Gidden, Curran Oi, Emily J Johnston, et al.
Plos One
|
June 5, 2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion
Evan Gomes-Giacoia, Makito Miyake, Steve Goodison, et al.
Cancer Gene Therapy
|
July 24, 2002
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer
Motoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, et al.
Page
of 51